BlackRock Investment Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$8.83M Buy
207,046
+26,569
+15% +$1.13M 0.01% 1193
2016
Q3
$8.56M Buy
180,477
+5,971
+3% +$298K 0.01% 1100
2016
Q2
$8.81M Buy
174,506
+7,848
+5% +$396K 0.01% 1042
2016
Q1
$8.06M Buy
166,658
+7,558
+5% +$292K 0.01% 1057
2015
Q4
$6.26M Buy
159,100
+5,215
+3% +$209K 0.01% 1243
2015
Q3
$5.84M Buy
153,885
+21,287
+16% +$898K 0.01% 1269
2015
Q2
$5.27M Buy
132,598
+23,322
+21% +$727K 0.01% 1455
2015
Q1
$2.93M Buy
109,276
+1,355
+1% +$38.2K ﹤0.01% 1766
2014
Q4
$3.17M Sell
107,921
-1,662
-2% -$41K ﹤0.01% 1697
2014
Q3
$2.21M Buy
109,583
+809
+0.7% +$15.6K ﹤0.01% 1929
2014
Q2
$1.82M Sell
108,774
-16,114
-13% -$228K ﹤0.01% 2148
2014
Q1
$1.86M Buy
124,888
+1,491
+1% +$22.9K ﹤0.01% 2091
2013
Q4
$1.8M Sell
123,397
-3,089
-2% -$49.7K ﹤0.01% 2095
2013
Q3
$2.18M Buy
126,486
+2,585
+2% +$38.3K ﹤0.01% 1893
2013
Q2
$1.44M Buy
+123,901
New +$1.42M ﹤0.01% 2109

Other funds holding AMED

BlackRock Investment Management's AMED Position: Q4 2016 in Review

BlackRock Investment Management increased its Amedisys (AMED) stake by 15% in Q4 2016, buying an estimated $1.13M and bringing the position to 207,046 shares worth $8.83M. The position accounts for 0.01% of the portfolio, ranked #1193.

BlackRock Investment Management first reported a position in AMED in Q2 2013 and has held it in 15 quarters since. 159 funds tracked by Wall St. Rank hold AMED as of Q4 2016.

  • BlackRock Investment Management held 207,046 shares of Amedisys worth $8.83M as of Q4 2016.
  • BlackRock Investment Management bought 26,569 Amedisys shares in Q4 2016, an estimated $1.13M.
  • Amedisys made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1193 holding.
  • BlackRock Investment Management first reported a position in Amedisys in Q2 2013 and has held it in 15 quarters since.
  • 159 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.